IGC Pharma (IGC) Intangibles (2011 - 2026)
IGC Pharma (IGC) reported Intangibles of $4.8 million for Q1 2026, up 758.33% year-over-year from $564000.0 in Q1 2025, and up 600.58% quarter-over-quarter from $691000.0 in Q4 2025.
IGC Pharma (IGC) Intangibles (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Intangibles data on file, last reported at $4.8 million in Q1 2026.
- Intangibles for Q1 2026 came in at $4.8 million, up 758.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 758.33% YoY), and the FY2026 annual result was $4.8 million, up 758.33% from the prior year.
- Intangibles advanced to $4.8 million in Q1 2026 per IGC's latest filing, from $691000.0 in the prior quarter.
- Over five years, Intangibles peaked at $4.8 million in Q1 2026 and troughed at $271000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $691000.0 in 2025 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles slumped 81.48% in 2025, then soared 758.33% in 2026.
- A 5-year view of Intangibles shows it stood at $476000.0 in 2022, then increased by 27.52% to $607000.0 in 2023, then dropped by 5.93% to $571000.0 in 2024, then increased by 21.02% to $691000.0 in 2025, then jumped by 600.58% to $4.8 million in 2026.
- Business Quant data shows IGC's Intangibles at $4.8 million in Q1 2026, $691000.0 in Q4 2025, and $334000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | 4.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.84 Mn |
| Dec 31, 2025 | 691,000.00 |
| Sep 30, 2025 | 334,000.00 |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 564,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 927,000.00 |
| Dec 31, 2023 | 607,000.00 |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 549,000.00 |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 476,000.00 |
| Sep 30, 2022 | 952,000.00 |
| Jun 30, 2022 | 444,000.00 |
| Mar 31, 2022 | 271,000.00 |
| Dec 31, 2021 | 152,000.00 |
| Sep 30, 2021 | 272,000.00 |
| Jun 30, 2021 | 221,000.00 |